Sign in

CIK 0001746466

  • Non-accelerated filer
  • Smaller reporting company

Equillium, Inc.

Sign in to watch
Ticker
EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821554746
Phone
+1 858-412-5302
Business address
2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
  1. 4 Planned sale Chief Financial Officer sold 10,000 shares at $0.65 ($6,500)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award Chief Financial Officer acquired 15,000 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Planned sale Chief Financial Officer sold 10,000 shares at $0.70 ($7,000)
  11. 4 Planned sale Sr. Vice President and COO sold 15,000 shares at $1.25 ($18,750)
  12. 4 Planned sale Principal Accounting Officer sold 3,518 shares at $1.25 ($4,398)
  13. 4 Planned sale Chief Financial Officer sold 10,000 shares at $0.81 ($8,100)
  14. 4 Planned sale Principal Accounting Officer sold 38,806 shares at $0.85 ($32,985)
  15. 4 Planned sale Chief Financial Officer sold 10,000 shares at $0.87 ($8,700)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 9 · 177 filings